As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Researchers couldn't be sure why the medicines, collectively known as GLP-1 agonists, may help in this way. But, experts ...

TikTok is full of wellness and health trends, and a leading doctor has shared his thoughts on the new 'Mounjaro drink' people ...

WEIGHT loss jabs slash alcohol cravings and can curb dangerous binge drinking, new research suggests.  The active drug ...

They work by mimicking the action of a hormone called glucagon-like peptide 1 (hence GLP-1), stimulating the body ... counterfeit semaglutides. In the UK, the Medicines and Healthcare products ...

The drug is also in development as a treatment for non-alcoholic steatohepatitis (NASH), another massive potential market, and Boehringer believes its double mechanism of action could allow it to ...

GLP1RA mimic the GLP-1 hormone in the body that helps control insulin and blood ... Strawbridge, PhD, of the University of Glasgow, in the UK.

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...